The Chelated Manganese Supplements market includes bioavailable manganese formulations bound to amino acids or organic ligands, enhancing absorption and bioavailability for dietary supplements, nutraceuticals, and functional foods. These supplements address micronutrient deficiencies, support bone health, and combat oxidative stress, positioning them as critical players in the global functional nutrition sector. The market size in 2025 is estimated at $210 million, reflecting steady adoption in health-conscious consumer segments and clinical applications. With a projected CAGR of 7.8% from 2026 to 2033, the growth outlook underscores the rising demand for targeted, science-backed nutrient solutions. Key macro drivers include the global increase in chronic disease prevalence, regulatory approvals for bioenhanced formulations, and the surge in personalized nutrition trends.